- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01648842
Vitamin D and Preeclampsia (FEPED)
Vitamin D Status in Pregnant Women With Preeclampsia
Study Overview
Status
Detailed Description
Primary purpose : To compare the vitamin D (25OHD) status, in the first trimester, in a group of patients with preeclampsia and a group of pregnant women without preeclampsia.
Secondary purpose : (i)To compare the vitamin D status in the third trimester in a group of patients with preeclampsia and a group of pregnant women without preeclampsia. (ii) To evaluate the deficit un vitamin D in a population of pregnant women in the parisian area. (iii) To evaluate the calcemia of the newborns after maternal systematic oral intake of vitamin D 100000U at 28 weeks Methodology : Multicenter (6 centers), Cohort, Nested case-control study Protocol : 4500 patients will be recruited. A blood sample will be performed : in the first trimester (11-14 weeks), in the third trimester (28-40 weeks), and cord blood. For each patient with preeclampsia, 4 controls will be taken from the cohort and matched by parity, race/ethnicity, maternal age, season, BMI. The serum concentration of 25OHD will be measured in all samples.A dosage of 25OHD will be performed in 1000 women from the initial cohort in order to calculate the prevalence of vitamin D deficiency.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Clamart, France, 92141
- Antoine Beclère Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Pregnant woman
- First trimester
- Singleton
- Affiliated to Social security policy
- Woman who gave informed consent
Exclusion Criteria:
- Hypercalcemia (>2.65 mmol/l) or any other phosphocalcic disease
- Hypertension (>140/90) from the first trimester
- Renal insufficiency (creatinine > 120µmol/l)
- Bone disease (osteogenesis imperfecta…)
- Lithium therapy
- Bowel malabsorption
- Kidney stones
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Pregnant women
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vitamin D (25OHD) status in the first trimester
Time Frame: 11-14 (+6) weeks of amenorrhea
|
To compare the vitamin D (25OHD) status, in the first trimester, in a group of patients with preeclampsia and a group of pregnant women without preeclampsia
|
11-14 (+6) weeks of amenorrhea
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Vitamin D status in the third trimester
Time Frame: 28-40 weeks of amenorrhea
|
To compare the vitamin D status in the third trimester in a group of patients with preeclampsia and a group of pregnant women without preeclampsia
|
28-40 weeks of amenorrhea
|
Deficit un vitamin D
Time Frame: 11-14 (+6) weeks of amenorrhea
|
To evaluate the deficit un vitamin D in a population of pregnant women in the parisian area
|
11-14 (+6) weeks of amenorrhea
|
Calcemia of the newborns
Time Frame: 1 day (At the moment of the Guthrie test)
|
To evaluate the calcemia of the newborns after maternal systematic oral intake of vitamin D
|
1 day (At the moment of the Guthrie test)
|
Collaborators and Investigators
Investigators
- Principal Investigator: Alexandra BENACHI, MD/PhD, Antoine Beclère Hospital
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AOM10113
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
-
University Hospital, ToursCompleted
-
Technische Universität DresdenWithdrawnPregnancy Trimester, Second | Pregnancy Trimester, First | Pregnancy Trimester, ThirdGermany
-
Turku University HospitalUniversity of TurkuCompleted
-
Hopital Antoine BeclereUnknown
-
Universitair Ziekenhuis BrusselMerck Serono International SAUnknownPregnancy | Pregnancy LossBelgium